ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 727049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 727049; 2) Community: the network communities that were significantly associated with the response to NSC 727049; 3) Molecule: the relationships between components within communities and NSC 727049; 4) MDR: the compounds that were significantly associated with the NSC 727049.

NSC Compound Enrichment Correlation
NSC 697886 17-Demethoxy-17-allylamino geldanamycin-11-[4-(dimethylamino)butyrate] 0.00645628049634956 0.33751463
NSC 706995 Entinostat 0.00645628049634956 0.15103319
NSC 725670 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline 0.00645628049634956 0.56216254
NSC 113423 NSC 113423 0.00862782236704185 0.340676
NSC 128635 Null 0.00862782236704185 0.62538129
NSC 132275 Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) 0.00862782236704185 0.51593109
NSC 21683 Null 0.00862782236704185 0.24017798
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.00862782236704185 0.57804855
NSC 359415 Null 0.00862782236704185 0.19114705
NSC 361605 Uracil, 5-fluoro-1-[tetrahydro-5-oxo-3-(trimethylsiloxy)-2-furanyl]-, (2S,trans)- 0.00862782236704185 0.28331714
Total:125  Current:37    [First] [Prev] [Next] [Last]